Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy

Details for Australian Patent Application No. 2001248324 (hide)

Owner University of Melbourne Southern Health Atkins, R. Chadban, S. Cooper, M. Gilbert, R. Hill, P. Kelly, D. Nikolic-Paterson, D.

Inventors Gilbert, Richard Ernest; Hill, Prudence Ann; Kelly, Darren James; NikolicPaterson, David John; Atkins, Robert Charles; Chadban, Steven James; Cooper, Mark Emmanuel

Agent Davies Collison Cave

Pub. Number AU-B-2001248324

PCT Pub. Number WO01/64200

Priority 00810181 03.03.00 EP

Filing date 1 March 2001

Wipo publication date 12 September 2001

Acceptance publication date 15 September 2005

International Classifications

A61K 031/00

A61K 031/505 - Pyrimidines

A61K 031/506 - not condensed and containing further heterocyclic rings

A61P 013/12 Drugs for disorders of the urinary system

Event Publications

15 September 2005 Application Accepted

  Published as AU-B-2001248324

19 January 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001248326

2001248323-Built-in lamp with a dome-shaped reflector